OM / Outset Medical: Revising To Buy, Market Dynamics, Guidance As Catalysts (Upgrade)

Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined w more_horizontal

The heavy selling pressure might have exhausted for Outset Medical, Inc. (OM) as it is technically in oversold territory now. In addition to this tech more_horizontal

Outset Medical Inc stock was downgraded by BofA Securities analysts to ‘Underperform' from ‘Buy', and its price objective was cut to $3 per share more_horizontal

Outset Medical Inc shares sank as much as 40% in pre-market trading on Friday after the medical technology company reported lower-than-expected prelim more_horizontal

Outset Medical, Inc. is commercializing a new hemodialysis machine for acute care and home settings. The company has reduced guidance due to pulling i more_horizontal

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to l more_horizontal

Outset Medical Inc's share price has risen by over 11% over the past year, but the company lacks a positive bottom line, making it a risky investment. more_horizontal

Outset said it received a Warning Letter from the FDA last week. The letter raised two new concerns regarding the company's dialysis products. more_horizontal